| LCTX Stock | | | USD 0.50 0.10 16.67% |
Lineage Cell financial indicator trend analysis is infinitely more than just investigating Lineage Cell Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Lineage Cell Therapeutics is a good investment. Please check the relationship between Lineage Cell Accounts Payable and its Net Debt accounts. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lineage Cell Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
Accounts Payable vs Net Debt
Accounts Payable vs Net Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Lineage Cell Therapeutics Accounts Payable account and
Net Debt. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Lineage Cell's Accounts Payable and Net Debt is 0.1. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Net Debt in the same time period over historical financial statements of Lineage Cell Therapeutics, assuming nothing else is changed. The correlation between historical values of Lineage Cell's Accounts Payable and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Lineage Cell Therapeutics are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Accounts Payable i.e., Lineage Cell's Accounts Payable and Net Debt go up and down completely randomly.
Correlation Coefficient | 0.1 |
| Relationship Direction | Positive |
| Relationship Strength | Insignificant |
Accounts Payable
An accounting item on the balance sheet that represents Lineage Cell obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Lineage Cell Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.
Most indicators from Lineage Cell's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lineage Cell Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lineage Cell Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
At this time, Lineage Cell's
Issuance Of Capital Stock is fairly stable compared to the past year.
Enterprise Value is likely to rise to about 206.5
M in 2024, whereas
Selling General Administrative is likely to drop slightly above 11
M in 2024.
Lineage Cell fundamental ratios Correlations
Click cells to compare fundamentals
Lineage Cell Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Lineage Cell fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Lineage Stock Analysis
When running Lineage Cell's price analysis, check to
measure Lineage Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lineage Cell is operating at the current time. Most of Lineage Cell's value examination focuses on studying past and present price action to
predict the probability of Lineage Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lineage Cell's price. Additionally, you may evaluate how the addition of Lineage Cell to your portfolios can decrease your overall portfolio volatility.